Table 1.
Performed diagnostics in the evaluation of suspected GLILD/exclusion of other pathology.
| No. (total 161) | Percentage (%) | |
|---|---|---|
| Blood | 118 | 73.3 |
| Aspergillus antigen blood test | 80 | 49.7 |
| Mycobacterium blood test | 80 | 49.7 |
| Beta D glucan blood test | 41 | 25.5 |
| Other blood tests* | 33 | 20.5 |
| Sputum | 121 | 75.2 |
| Bacteria | 108 | 67.1 |
| Mycobacteria | 108 | 67.1 |
| Fungal pathogens | 90 | 55.9 |
| Viral pathogens | 43 | 26.7 |
| Other sputum tests | 5 | 3.1 |
| Bronchoalveolar lavage | 129 | 80.1 |
| Bacteria | 124 | 77 |
| Mycobacteria | 121 | 75.2 |
| Fungal pathogens | 119 | 73.9 |
| Viral pathogens | 87 | 54 |
| Other bronchoalveolar lavage tests** | 39 | 24.2 |
| Lung biopsy | 39 | 24.2 |
| Bacteria | 22 | 13.7 |
| Mycobacteria | 30 | 18.6 |
| Fungal pathogens | 26 | 16.1 |
| Viral pathogens | 17 | 10.6 |
| Other biopsy tests | 11 | 6.8 |
*Other blood tests include culture, autoantibody panel, beta 2 microglobulin, soluble CD25, cytology differential, Igs, procalcitonin, PCR EBV, and CMV. **Other bronchoalveolar lavage tests include next generation sequencing of pathogens, galactomannan, flow cytometry.